Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 β-lactamases at 2 hospitals in Taiwan

Diagnostic Microbiology and Infectious Disease

Volumn 54, Issue 2, 2006, Pages 89-94

  Wu, Lii Tzu ^a   Wu, Hwa Jen ^b   Chung, Jing Gung ^a   Chuang, Yin Ching ^c   Cheng, Kuo Chen ^c   Yu, Wen Liang ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b JEN AI HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Lactamases; CTX M; Proteus mirabilis

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 3; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GENOMIC DNA; GENTAMICIN; ISEPAMICIN; MEROPENEM; PIPERACILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE SEQUENCE; GENOTYPE; ISOELECTRIC FOCUSING; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEUS MIRABILIS; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; GENOME, BACTERIAL; GENOTYPE; HOSPITALS, DISTRICT; HUMANS; LACTAMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEUS INFECTIONS; PROTEUS MIRABILIS; RESPIRATORY TRACT INFECTIONS; TAIWAN; URINARY TRACT INFECTIONS;

EID: 31744449484     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2005.09.005     Document Type: Article

References (31)

1. P. Bidet, C. Verdet, V. Gautier, E. Bingen, and G.. Arlet First description of DHA-1 ampC β-lactamase in Proteus mirabilis Clin. Microbiol. Infect. 11 2005 591 592
2. M. Biendo, D. Thomas, G. Laurans, F. Hamdad-Daoudi, B. Canarelli, F. Rousseau, S. Castelain, and F. Eb Molecular diversity of Proteus mirabilis isolates producing extended-spectrum β-lactamases in a French university hospital Clin. Microbiol. Infect. 11 2005 395 401
3. H.C. Birnboim, and J. Doly A rapid alkaline extraction procedure for screening recombinant plasmid DNA Nucleic. Acids. Res. 7 1979 1513 1523
4. R. Bonnet Growing group of extended-spectrum β-lactamases: the CTX-M enzymes Antimicrob. Agents Chemother. 48 2004 1 14
5. R. Bonnet, C. De Champs, D. Sirot, C. Chanal, R. Labia, and J. Sirot Diversity of TEM mutants in Proteus mirabilis Antimicrob. Agents Chemother. 43 1999 2671 2677
6. R. Bonnet, J.L. Sampaio, R. Labia, C. De Champs, D. Sirot, C. Chanal, and J. Sirot A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil Antimicrob. Agents Chemother. 44 2000 1936 1942
7. G. Bou, M. Cartelle, M. Tomas, D. Canle, F. Molina, R. Moure, J.M. Eiros, and A. Guerrero Identification and broad dissemination of the CTX-M-14 β-lactamase in different Escherichia coli strains in the northwest area of Spain J. Clin. Microbiol. 40 2002 4030 4036
8. J.M. Casellas, M. Visser, G. Tome, H. Cohen, J. Soutric, and H. Arenoso Escherichia coli eradication from the bladder urine by amoxicillin-sulbactam. Intrinsic activity of the inhibitor Enferm. Infecc. Microbiol. Clin. 19 2001 206 210
9. S.N. Cohen, A.C.Y. Chang, and L. Hsu Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA Proc. Natl. Acad. Sci. U. S. A. 69 1972 2110 2114
10. C. Coker, C.A. Poore, X. Li, and H.L. Mobley Pathogenesis of Proteus mirabilis urinary tract infection Microbes Infect. 2 2000 1497 1505
11. P.L. Ho, A.Y. Ho, K.H. Chow, R.C. Wong, R.S. Duan, W.L. Ho, G.C. Mak, K.W. Tsang, W.C. Yam, and K.Y. Yuen Occurrence and molecular analysis of extended-spectrum β-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002 J. Antimicrob. Chemother. 55 2005 840 845
12. Y. Horiguchi, G. Hashikita, Y. Oka, S. Takahashi, T. Yamazaki, S. Maesaki, and Y. Ishii Study of resistance mechanism on cefotaxime resistant Proteus mirabilis isolated from clinical specimens and its clinical background Kansenshogaku. Zasshi. 78 2004 1 9
13. L. Ma, Y. Ishii, F.Y. Chang, K. Yamaguchi, M. Ho, and L.K. Siu CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum β-lactamase isolated from Escherichia coli Antimicrob. Agents Chemother. 46 2002 1985 1988
14. A. Mathew, A.M. Harris, M.J. Marshall, and G.W. Ross The use of analytical isoelectric focusing for detection and identification of β-lactamases J. Gen. Microbiol. 88 1975 169 178
15. N. Nagano, N. Shibata, Y. Saitou, Y. Nagano, and Y. Arakawa Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β-lactamase J. Clin. Microbiol. 41 2003 5530 5536
16. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests. Supplemental tables M100-S13 2003 National Committee for Clinical Laboratory Standards Wayne (PA)
17. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Supplemental tables M100-S13 2003 National Committee for Clinical Laboratory Standards Wayne (PA)
18. L. Pagani, R. Migliavacca, L. Pallecchi, C. Matti, E. Giacobone, G. Amicosante, E. Romero, and G.M. Rossolini Emerging extended-spectrum β-lactamases in Proteus mirabilis J. Clin. Microbiol. 40 2002 1549 1552
19. H. Pai, S. Lyu, J.H. Lee, J. Kim, Y. Kwon, J.W. Kim, and K.W. Choe Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea J. Clin. Microbiol. 37 1999 1758 1763
20. H. Pai, E.H. Choi, H.J. Lee, J.Y. Hong, and G.A. Jacoby Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea J. Clin. Microbiol. 39 2001 3747 3749
21. T. Palzkill, K.S. Thomson, C.C. Sanders, E.S. Moland, W. Huang, and T.W. Milligan New variant of TEM-10 β-lactamase gene produced by a clinical isolate of Proteus mirabilis Antimicrob. Agents Chemother. 39 1995 1199 1200
22. M. Quinteros, M. Radice, N. Gardella, M.M. Rodriguez, N. Costa, D. Korbenfeld, E. Couto, and G. Gutkind Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals Antimicrob. Agents Chemother. 47 2003 2864 2867
23. E. Tzelepi, P. Giakkoupi, D. Sofianou, V. Loukova, A. Kemeroglou, and A. Tsakris Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes J. Clin. Microbiol. 38 2000 542 546
24. L.S. Tzouvelekis, E. Tzelepi, P.T. Tassios, and N.J. Legakis CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes Int. J. Antimicrob. Agents 14 2000 137 142
25. J. Walther-Rasmussen, and N. Hoiby Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases Can. J. Microbiol. 50 2004 137 165
26. P.L. Winokur, R. Canton, J.M. Casellas, and N. Legakis Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region Clin. Infect. Dis. 32 2001 S94 S103
27. L.T. Wu, M.F. Tsou, J.J. Wu, H.E. Chen, Y.C. Chuang, and W.L. Yu Survey of CTX-M-3 extended-spectrum β-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan Diagn. Microbiol. Infect. Dis. 49 2004 125 129
28. J.J. Yan, W.C. Ko, S.H. Tsai, H.M. Wu, Y.T. Jin, and J.J. Wu Dissemination of CTX-M-3 and CMY-2 β-lactamases among clinical isolates of Escherichia coli in southern Taiwan J. Clin. Microbiol. 38 2000 4320 4325
29. J.J. Yan, W.C. Ko, Y.C. Jung, C.L. Chuang, and J.J. Wu Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan J. Clin. Microbiol. 40 2002 3121 3126
30. D. Yong, Y. Lim, W. Song, Y.S. Choi, D.Y. Park, H. Lee, J.H. Yum, K. Lee, J.M. Kim, and Y. Chong Plasmid-mediated, inducible AmpC β-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis Diagn. Microbiol. Infect. Dis. 53 2005 65 70
31. W.L. Yu, P.L. Winokur, D.L. Von Stein, M.A. Pfaller, J.H. Wang, and R.N. Jones First description of Klebsiella pneumoniae harboring CTX-M β-lactamases (CTX-M-14 and CTX-M-3) in Taiwan Antimicrob. Agents Chemother. 46 2002 1098 1100